Key facts
- It has raised $3.5M; the latest was Early Stage VC ($3.5M) in Dec 2025.
- Notable investors include Speedinvest, HV Capital Manager.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for MPiriQ
- ·The full record, as it builds
Funding rounds
No funding rounds for MPiriQ are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MPiriQ
Developer of a software infrastructure designed for clinical data management and research purposes. The company's platform structures and pseudonymizes patient data, automates documentation, integrates with existing systems, validates data in real time, and secures compliance, enabling healthcare providers and researchers to streamline workflows and accelerate evidence generation.
- Sector
- Healthcare
- HQ
- Munich, Germany
- Founded
- 2024
- Employees
- 13
- Website
- mpiriq.de/
- Ownership
- Privately Held (backing)
MPiriQ doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MPiriQ shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MPiriQ in its N-PORT filings yet. We sweep new filings monthly.